Nos publications
Mise à jour août 2024
Pagination
- Page précédente
- Page 16
- Page suivante
Title | Authors | Year Trier par ordre croissant | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Circulaire d'information utilisation de composants sanguins humains: Plaquettes | Stewart T | 2022 | Blood.ca website | View Circulaire d'information utilisation de composants sanguins humains: Plaquettes | Health care providers | Benchmarking and standard setting |
Utilization of a surgical database to provide care and assess perioperative treatment and outcomes in patients with bleeding disorders | Olasupo OO, Haddix C, Nakar C, Maahs J, Greist A, Ghafoor A, Donfield SM, Iorio A, Shapiro AD | 2022 | Eur J Haematol | View Utilization of a surgical database to provide care and assess perioperative treatment and outcomes in patients with bleeding disorders | Health care providers | Benchmarking and standard setting |
HIV incidence and compliance with deferral criteria over three progressively shorter time deferrals for men who have sex with men in Canada | Caffrey N, Goldman M, Osmond L, Yi Q-L, Fan W, O'Brien SF | 2022 | Transfusion | View HIV incidence and compliance with deferral criteria over three progressively shorter time deferrals for men who have sex with men in Canada | Regulators | MSM research |
Transfusion thresholds in myelodysplastic syndrome - Helping patients live better | Balitsky A, Arnold D | 2022 | Transfusion | View Transfusion thresholds in myelodysplastic syndrome - Helping patients live better | Health care providers | Clinical research |
A cross-sectional study of haemolytic disease of the newborn in Uganda | Dhabangi A, Nankunda J, Okaba V, Nakubulwa S, Hume HA, Dzik WH, Heddle NM | 2022 | Vox Sang | View A cross-sectional study of haemolytic disease of the newborn in Uganda | Health care providers | Clinical research |
The Cost Effectiveness of Axicabtagene Ciloleucel Versus Best Supportive Care in the Treatment of Adult Patients with Relapsed or Refractory Large B-Cell Lymphoma (LBCL) After Two or More Lines of Systemic Therapy in Canada | Hillis C, Vicente C, Ball G | 2022 | Pharmacoeconomics | View The Cost Effectiveness of Axicabtagene Ciloleucel Versus Best Supportive Care in the Treatment of Adult Patients with Relapsed or Refractory Large B-Cell Lymphoma (LBCL) After Two or More Lines of Systemic Therapy in Canada | Researchers | Clinical research |
The evaluation of constant coronary artery flow versus constant coronary perfusion pressure during normothermic ex situ heart perfusion | Qi X, Hatami S, Bozso S, Buchko M, Forgie KA, Olafson C, Khan M, Himmat S, Wang X, Nobes DS, Acker JP, Nagendran J, Freed DH | 2022 | J Heart Lung Transplant | View The evaluation of constant coronary artery flow versus constant coronary perfusion pressure during normothermic ex situ heart perfusion | Researchers | Basic research |
Summary of adverse transfusion reactions 2017-2022 | Yan M | 2022 | Blood.ca website | View Summary of adverse transfusion reactions 2017-2022 | Blood operators | Benchmarking and standard setting |
Circular of information for the use of human blood components: Pathogen Reduced Platelet Concentrates | Stewart T | 2022 | Blood.ca website | View Circular of information for the use of human blood components: Pathogen Reduced Platelet Concentrates | Health care providers | Benchmarking and standard setting |
International Forum on Gender Identification and Blood Collection: Summary | Pandey S, Gorlin JB, Townsend M, Van Buren N, Leung JNS, Lee CK, van den Hurk K, Casamitjana N, Valles R, Alonso E, Miller YM, Richard P, Woimant G, Tiberghien P, Zhiburt E, Butler-Foster T, Goldman M, Nissen-Meyer LSH, Espinosa A, Kamel H, Bravo M, Filho LA, Pecego M, Germain M, Rabusseau I, Shinar E, Raz H, Choudhury N, Bhatnagar N, Hurt K, Lopez M, Reik RA, Nie Y, Hung Y, Pheello L, Dunbar N | 2022 | Vox Sang | View International Forum on Gender Identification and Blood Collection: Summary | Blood operators | Benchmarking and standard setting |
ResearchUnit: Whole blood: longer holding times before leukoreduction may be a safe to explore option | Chen ZY | 2022 | Blood.ca website | View ResearchUnit: Whole blood: longer holding times before leukoreduction may be a safe to explore option | Regulators | New or improved product or process |
Spotlight on animal models of acute traumatic coagulopathy: An update | Ask A, Eltringham-Smith L, Bhakta V, Donkor DA, Pryzdial ELG, Sheffield WP | 2022 | Transfus Apher Sci | View Spotlight on animal models of acute traumatic coagulopathy: An update | Researchers | Basic research |
A naturally present autoantibody to senescent red blood cells? | Badior KE, Bloch EM, Branch DR | 2022 | Transfusion | View A naturally present autoantibody to senescent red blood cells? | Researchers | Benchmarking and standard setting |
Opposing roles of CLK SR kinases in controlling HIV-1 gene expression and latency | Dahal S, Clayton K, Been T, Fernet-Brochu R, Ocando AV, Balachandran A, Poirier M, Maldonado RK, Shkreta L, Boligan KF, Guvenc F, Rahman F, Branch D, Bell B, Chabot B, Gray-Owen SD, Parent LJ, Cochrane A | 2022 | Retrovirology | View Opposing roles of CLK SR kinases in controlling HIV-1 gene expression and latency | Researchers | Basic research |
A data-driven approach to determine daily platelet order quantities at hospitals | Mirjalili M, Abouee-Mehrizi H, Barty R, Heddle NM, Sarhangian V | 2022 | Transfusion | View A data-driven approach to determine daily platelet order quantities at hospitals | Researchers | New or improved product or process |
Chapitre 5. Concentrés pour les troubles de l’hémostase et l’angiœdème héréditaire | Poon MC, Goodyear D, Rydz N, Lee A | 2022 | Guide de la pratique transfusionnelle | View Chapitre 5. Concentrés pour les troubles de l’hémostase et l’angiœdème héréditaire | Health care providers | Benchmarking and standard setting |
Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia | Kaur MN, Arnold DM, Heddle NM, Cook RJ, Hsia C, Blostein M, Jamula E, Sholzberg M, Lin Y, Kassis J, Larratt L, Tinmouth A, Carruthers J, Li N, Liu Y, Xie F | 2022 | Blood Adv | View Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia | Health care providers | Clinical research |
Loss of repeat convalescent plasma donors due to waning anti-SARS-CoV-2 plaque reduction neutralization test titers (April-December 2020) | Drews S, Devine D, McManus J, Mendoza E, Manguiat K, Girardin R, Dupuis A, McDonough K, Lin J, Evans D, Pambrun C, Drebot M, Wood H | 2022 | Transfus Med Rev | View Loss of repeat convalescent plasma donors due to waning anti-SARS-CoV-2 plaque reduction neutralization test titers (April-December 2020) | Blood operators | New or improved product or process |
Plaquettes extraites de la couche leucoplaquettaire à teneur réduite en agents pathogènes | Blais-Normandin I, Tordon B, Anani W | 2022 | Blood.ca website | View Plaquettes extraites de la couche leucoplaquettaire à teneur réduite en agents pathogènes | Health care providers | Benchmarking and standard setting |
Methods to Evaluate the Potential Clinical Significance of Antibodies to Red Blood Cells | Boligan KF, Sandhu G, Branch DR | 2022 | Curr Protoc | View Methods to Evaluate the Potential Clinical Significance of Antibodies to Red Blood Cells | Researchers | Benchmarking and standard setting |
Management of immune‐mediated thrombocytopenia | Gabe C, Arnold D, Smith J, T W | 2022 | Rossi's Principles of Transfusion Medicine | View Management of immune‐mediated thrombocytopenia | Health care providers | Benchmarking and standard setting |
Why We Swab: A library of stories in stem cell donation | Jagelaviciute G, Kum E, Li EW, Rosenfeld A, Williams K, Kandel R, DeGurse N, Park B, Okonofua S, Sano L, Gerofsky M, Sharp A, Hatkar R, Thyagu S, Fingrut WB | 2022 | Transfusion | View Why We Swab: A library of stories in stem cell donation | Health care providers | Ethical, legal & social implications research |
Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses | Lin Y-CJ, Evans DH, Robbins NF, Orjuela G, Hu Q, Samson R, Abe KT, Rathod B, Colwill K, Gingras A-C, Tuite A, Yi Q-L, O’Brien SF, Drews SJ | 2022 | Microbiol Spectr | View Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses | Health care providers | Benchmarking and standard setting |
Les fournisseurs de sang canadiens : un rôle croissant dans la surveillance de la santé publique? | O’Brien SF, Drews SJ, Lewin A, Osiowy C, Drebot MA, Renaud C | 2022 | Relevé des maladies transmissibles au Canada | View Les fournisseurs de sang canadiens : un rôle croissant dans la surveillance de la santé publique? | Health care providers | New or improved product or process |
Resistance of SARS-CoV-2 beta and gamma variants to plasma collected from Canadian blood donors during the spring of 2020 | Drews SJ, Abe KT, Hu Q, Samson R, Gingras A-C, Colwill K, Rathod B, Wang J, Fazel-Zarandi M, Yi Q-L, Robinson A, Wood H, Tuite A, Fisman D, Evans DH, Lin Y-CJ, O'Brien SF | 2022 | Transfusion | View Resistance of SARS-CoV-2 beta and gamma variants to plasma collected from Canadian blood donors during the spring of 2020 | Researchers | Clinical research |
Epidemiology of Hospitalized Patients with Babesiosis, United States, 2010-2016 | Bloch EM, Day JR, Krause PJ, Kjemtrup A, O'Brien SF, Tobian AAR, Goel R | 2022 | Emerg Infect Dis | View Epidemiology of Hospitalized Patients with Babesiosis, United States, 2010-2016 | Health care providers | Clinical research |
Bacterial contamination of blood components | Bloch EM, Benjamin RJ, Ramirez-Arcos S | 2022 | Rossi's Principles of Transfusion Medicine | View Bacterial contamination of blood components | Health care providers | Benchmarking and standard setting |
Closed system processing variables affect post-thaw quality characteristics of cryopreserved red cell concentrates | Howell A, Turner TR, Hansen A, Lautner LJ, Yi Q, Acker JP | 2022 | Transfusion | View Closed system processing variables affect post-thaw quality characteristics of cryopreserved red cell concentrates | Researchers | Basic research |
Development and validation of a sensitive flow cytometric method for determining CECs in RBC products | Li W, Acker JP | 2022 | Clin Chim Acta | View Development and validation of a sensitive flow cytometric method for determining CECs in RBC products | Researchers | New or improved product or process |
Canadian blood suppliers: An expanding role in public health surveillance? | O'Brien SF, Drews SJ, Lewin A, Osiowy C, Drebot MA, Renaud C | 2022 | Can Commun Dis Rep | View Canadian blood suppliers: An expanding role in public health surveillance? | Health care providers | New or improved product or process |
Minimal impact of anticoagulant on in vitro whole blood quality throughout a 35-day cold-storage regardless of leukoreduction timing | Schubert P, Culibrk B, Bhakta V, Closas T, Sheffield WP, Devine DV, McTaggart K | 2022 | Transfusion | View Minimal impact of anticoagulant on in vitro whole blood quality throughout a 35-day cold-storage regardless of leukoreduction timing | Researchers | Basic research |
Novel contact–kinin inhibitor sylvestin targets thromboinflammation and ameliorates ischemic stroke | Zhang Z, Shen C, Fang M, Han Y, Long C, Liu W, Yang M, Liu M, Zhang D, Cao Q, Chen X, Fang Y, Lu Q, Hou Z, Li Y, Liu Z, Lei X, Ni H, Lai R | 2022 | Cell Mol Life Sci | View Novel contact–kinin inhibitor sylvestin targets thromboinflammation and ameliorates ischemic stroke | Researchers | Basic research |
A mixed methods investigation of the relationship between blood donor policy, interest in donation, and willingness to donate among gay, bisexual, and other men who have sex with men in Ontario, Canada | Armstrong JP, Brennan DJ, Collict D, Kesler M, Bekele T, Souleymanov R, Grace D, Lachowsky NJ, Hart TA, Adam BD | 2022 | BMC Public Health | View A mixed methods investigation of the relationship between blood donor policy, interest in donation, and willingness to donate among gay, bisexual, and other men who have sex with men in Ontario, Canada | Researchers | MSM research |
Staff perspectives on barriers and enablers to implementing alternative source plasma eligibility criteria for gay, bisexual, and other men who have sex with men | Castillo G, Vesnaver E, Gibson E, Butler-Foster T, Goldman M, Hill NE, Rosser A, Lapierre D, Rubini KA, MacDonagh R, Miguel G, Palumbo A, MacPherson P, Randall T, Osbourne-Sorrell W, O'Brien SF, Bridel W, Otis J, Greaves M, Al-Bakri TB, Reid M, Labrecque M, Germain M, Orvis S, Clapperton AT, Devine D, Presseau J | 2022 | Transfusion | View Staff perspectives on barriers and enablers to implementing alternative source plasma eligibility criteria for gay, bisexual, and other men who have sex with men | Blood operators | MSM research |
A Prospective Observational Cohort Comparison of SARS-CoV-2 Seroprevalence Between Paramedics and Matched Blood Donors in Canada During the COVID-19 Pandemic | Grunau B, O’Brien SF, Kirkham TL, Helmer J, Demers PA, Asamoah-Boaheng M, Drews SJ, Karim ME, Srigley JA, Sediqi S, O’Neill D, Drennan IR, Goldfarb DM | 2022 | Ann Emerg Med | View A Prospective Observational Cohort Comparison of SARS-CoV-2 Seroprevalence Between Paramedics and Matched Blood Donors in Canada During the COVID-19 Pandemic | Researchers | Clinical research |
Déclaration du CCN concernant le génotypage du RHD chez les patientes enceintes | Pavenski K, Khandelwal A, Clarke G, Lane D | 2022 | National Advisory Committee on Blood and Blood Products | View Déclaration du CCN concernant le génotypage du RHD chez les patientes enceintes | Health care providers | Benchmarking and standard setting |
Bacterial contamination of platelet components | Ramirez-Arcos S, McDonald C, ISBT Transfusion-Transmitted Infectious Disease Bacterial Working Party Bacterial Subgroup | 2022 | Ann Blood | View Bacterial contamination of platelet components | Blood operators | Benchmarking and standard setting |
Behaviour based screening questions and potential donation loss using the “for the assessment of individualised risk” screening criteria: A Canadian perspective | Caffrey N, Goldman M, Lewin A, Osmond L, O'Brien SF | 2022 | Transfus Med | View Behaviour based screening questions and potential donation loss using the “for the assessment of individualised risk” screening criteria: A Canadian perspective | Researchers | MSM research |
Screening for high-risk sexual behavior in Canada | Goldman M, Caffrey N, O'Brien SF | 2022 | Transfusion | View Screening for high-risk sexual behavior in Canada | Blood operators | Clinical research |
FAQ: Whole blood, leukocytes reduced (LrWB) at Canadian Blood Services | Mack J | 2022 | Blood.ca website | View FAQ: Whole blood, leukocytes reduced (LrWB) at Canadian Blood Services | Health care providers | New or improved product or process |
T cell-mediated autoimmunity in immune thrombocytopenia | Vrbensky JR, Nazy I, Clare R, Larché M, Arnold DM | 2022 | Eur J Haematol | View T cell-mediated autoimmunity in immune thrombocytopenia | Researchers | Clinical research |
Circulaire d'information utilisation de composants sanguins humains: Cellules progénitrices hématopiétiques de sang de cordon omilical | Stewart T | 2022 | Blood.ca website | View Circulaire d'information utilisation de composants sanguins humains: Cellules progénitrices hématopiétiques de sang de cordon omilical | Health care providers | Benchmarking and standard setting |
Implementation of a blood bank generated tube for second blood group determination: Challenges, yield, and cost | Obaidallah N, Downie H, Colavecchia C, Callum J, Lin Y | 2022 | Transfusion | View Implementation of a blood bank generated tube for second blood group determination: Challenges, yield, and cost | Health care providers | New or improved product or process |
Impact of cardiopulmonary bypass duration on efficacy of fibrinogen replacement with cryoprecipitate compared with fibrinogen concentrate: a <em>post hoc</em> analysis of the Fibrinogen Replenishment in Surgery (FIBRES) randomised controlled trial | Bartoszko J, Martinez-Perez S, Callum J, Karkouti K, Farouh ME, Scales DC, Heddle NM, Crowther M, Rao V, Hucke H-P, Carroll J, Grewal D, Brar S, Brussières J, Grocott H, Harle C, Pavenski K, Rochon A, Saha T, Shepherd L, Syed S, Tran D, Wong D, Zeller M | 2022 | Br J Anaesth | View Impact of cardiopulmonary bypass duration on efficacy of fibrinogen replacement with cryoprecipitate compared with fibrinogen concentrate: a <em>post hoc</em> analysis of the Fibrinogen Replenishment in Surgery (FIBRES) randomised controlled trial | Researchers | Clinical research |
Evaluation of the performance of multiple immunoassay diagnostic platforms on the National Microbiology Laboratory SARS-CoV-2 National Serology Panel | Dibernardo A, Toledo NP, Robinson A, Osiowy C, Giles E, Day J, Lindsay LR, Drebot MA, Booth TF, Pidduck T, Baily A, Charlton CL, Tipples G, Kanji JN, Brochu G, Lang A, Therrien C, Bélanger-Collard M, Beaulac S-N, Gilfix BM, Boivin G, Hamelin M-È, Carbonneau J, Lévesque S, Martin P, Finzi A, Gendron-Lepage G, Goyette G, Benlarbi M, Gasser R, Fortin C, Martel-Lafferrière V, Lavoie M, Guérin R, Haraoui L-P, Renaud C, Jenkins C, O'Brien SF, Drews SJ, Conrod V, Tran V, Awrey B, Scheuermann R, DuPuis A, Payne A, Warszycki C, Girardin R, Lee W, Zahariadis G, Jiao L, Needle R, Cordenbach J, Zaharatos J, Taylor K, Teltscher M, Miller M, Elsherif M, Robertson P, Robinson JL | 2022 | J Assoc Med Microbiol Infect Dis Can | View Evaluation of the performance of multiple immunoassay diagnostic platforms on the National Microbiology Laboratory SARS-CoV-2 National Serology Panel | Researchers | Benchmarking and standard setting |
The bending rigidity of the red blood cell cytoplasmic membrane | Himbert S, D’Alessandro A, Qadri SM, Majcher MJ, Hoare T, Sheffield WP, Nagao M, Nagle JF, Rheinstädter MC | 2022 | PLoS One | View The bending rigidity of the red blood cell cytoplasmic membrane | Researchers | Basic research |
FAQ: Information for health professionals on pathogen-reduced platelets | Ning S, Tordon B, Zeller M, Anani W | 2022 | Blood.ca website | View FAQ: Information for health professionals on pathogen-reduced platelets | Health care providers | New or improved product or process |
Whole blood donor return rates after deferral for tattooing or body piercing—Survey across blood donation services: The BEST collaborative study | Quee F, O'Brien SF, Prinsze F, Steele WR, Grégoire Y, Cutajar A, Wendel S, Compernolle V, Goldman M, van den Hurk K, Biomedical Excellence for Safer Transfusion Collaborative | 2022 | Vox Sang | View Whole blood donor return rates after deferral for tattooing or body piercing—Survey across blood donation services: The BEST collaborative study | Blood operators | Benchmarking and standard setting |
Sommaire des réactions transfusionnelles indésirables | Yan M | 2022 | Blood.ca website | View Sommaire des réactions transfusionnelles indésirables | Blood operators | Benchmarking and standard setting |
Circular of information for the use of human blood components: Platelets | Stewart T | 2022 | Blood.ca website | View Circular of information for the use of human blood components: Platelets | Health care providers | Benchmarking and standard setting |